Company intelligence / Profile preview

Hong Kong Taikuk (China) Group Limited

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Hong Kong Taikuk (China) Group Limited is a private company limited by shares, founded in 2010 and headquartered in Hong Kong. It is active in the healthcare sector, specifically involved in commercial joint ventures. A key partnership includes a 2022 joint venture with ChromaDex Corporation for commercializing NAD+ precursor products, such as Tru Niagen, in the Asia/China market.

Industry: Food & Nutrition

Partnerships

ChromaDex Corporation (joint venture for commercializing Tru Niagen in Asia/China)Crystal Lake Developments LimitedPioneer Idea Holdings Limited

Beyond the preview

Go deeper on Hong Kong Taikuk (China) Group Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hong Kong Taikuk (China) Group Limited.

Explore the full profile